🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Telangiectasias

Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families NCT00230620n/a1 site📍 London Imperial College London Safety and Efficacy of Mutation-targeted Precision Genetic Therapy for Ataxia-Telangiectasia (A-T) NCT07215416Phase 1, Phase 21 site📍 Boston Timothy Yu · Tests: Antisense oligonucleotide targeting the ATM gene An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors NCT07371663Phase 1, Phase 23 sites📍 Beijing📍 Zhengzhou📍 Hangzhou Beijing Tide Pharmaceutical Co., Ltd · Tests: TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg, benmelstobart Injection Body Donation in HHT NCT07826845NA1 site📍 Essen University Hospital, Essen · Tests: body donation in HHT A Trial to Assess the Efficacy and Safety of Engasertib in Participants With Moderate to Severe Hereditary Hemorrhagic Telangiectasia (HHT) NCT07743671Phase 34 sites📍 Chicago📍 Indianapolis📍 Rochester Vaderis Therapeutics AG · Tests: Engasertib, Placebo Bevacizumab in the Treatment of HHT NCT07828015Phase 21 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Bevacizumab, nasal electrocoagulation., Thalidomide (50mg) A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors NCT04657068Phase 1, Phase 288 sites📍 Birmingham📍 Scottsdale📍 Little Rock Artios Pharma Ltd · Tests: ART0380, Gemcitabine, Irinotecan Pregnancy in Women With Rare Multisystemic Vascular Diseases: COGRare5 Study NCT04194619n/a37 sites📍 Angers📍 Bordeaux📍 Bordeaux Hospices Civils de Lyon · Tests: Questionnaire Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases NCT00874783n/a1 site📍 Jerusalem Hadassah Medical Organization Dermocosmetic Treatment for Facial Redness in Rosacea With or Without Laser Therapy NCT07521462NA1 site📍 Rouen ISISPHARMA · Tests: Dermocosmetic tested product, Placebo, Vascular laser treatment Comprehensive HHT Outcomes Registry of the United States (CHORUS) NCT06259292n/a16 sites📍 Birmingham📍 Los Angeles📍 San Francisco Cure HHT Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic Telangiectasia NCT04469517n/a1 site📍 Essen University Hospital, Essen · Tests: hypoxic induced factors Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health Quality of Life in Pediatric Participants With HHT NCT07474428n/a1 site📍 Cincinnati Ashley Nelson Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia NCT00230685n/a1 site📍 London Imperial College London Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia NCT05641142NA18 sites📍 Angers📍 Bordeaux📍 Boulogne-Billancourt University Hospital, Clermont-Ferrand · Tests: monitoring the use of anticoagulant and/or antiplatelet therapy in patients with osler rendering disease The Cancer of the Pancreas Screening-5 CAPS5)Study NCT02000089Phase 39 sites📍 New Haven📍 Baltimore📍 Boston Johns Hopkins University · Tests: Secretin, MRI, Tumor marker gene test with CA19-9 DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia NCT07623525Phase 1, Phase 211 sites📍 Camperdown📍 Randwick📍 Herston Diagonal Therapeutics, Inc. · Tests: DIAG723, Placebo Institutional Registry of Rare Diseases NCT06573723n/a1 site📍 Buenos Aires Hospital Italiano de Buenos Aires Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT) NCT07601425Phase 1, Phase 27 sites📍 Phoenix📍 Augusta📍 Indianapolis Atavistik Bio, Inc · Tests: ATV-1601, Placebo Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients NCT04976036Phase 23 sites📍 Bron📍 Clermont-Ferrand📍 Lausanne Dr. Romain Lazor · Tests: Nintedanib, Placebo Institutional Registry of Haemorrhagic Hereditary Telangiectasia NCT01761981n/a1 site📍 Buenos Aires Hospital Italiano de Buenos Aires Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants NCT06971939Phase 426 sites📍 La Jolla📍 Los Angeles📍 Palo Alto Neurotech Pharmaceuticals · Tests: NT-501/revakinagene taroretcel-lwey Immunological Effects of Iron Supplementation in HHT Disease NCT07111598NA1 site📍 Bron Hospices Civils de Lyon · Tests: Blood test at D0, Blood test at D+3 months Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries NCT06520410Phase 41 site📍 Taoyuan Chang Gung Memorial Hospital · Tests: Pars plana vitrectomy with a 18 mm short vitrector Partial Breast Versus no Irradiation for Women With Early Breast Cancer NCT03646955NA17 sites📍 Santiago📍 Aalborg📍 Aarhus Danish Breast Cancer Cooperative Group · Tests: No partial breast irradiation Foam Sclerotherapy With or Without Transdermal Laser for Reticular Veins and Telangiectasias NCT07793630Phase 41 site📍 Ribeirão Preto University of Sao Paulo · Tests: Polidocanol foam sclerotherapy, Transdermal 1064 nm Nd:YAG Laser Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness NCT05691491Phase 1, Phase 223 sites📍 Irvine📍 La Jolla📍 Orange National Cancer Institute (NCI) · Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Temozolomide A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change NCT05010031Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Palliative radiotherapy Non-Invasive Detection of Pulmonary Right-to-Left Shunts Using the SONAS Ultrasound Device NCT07414446NA1 site📍 Nieuwegein St. Antonius Hospital · Tests: Transcranial Ultrasound Device
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy